Related Experiment Videos
Mode of action of morpholine derivatives
1F. Hoffmann-La Roche & Co., Ltd., Basel, Switzerland.
Annals of the New York Academy of Sciences
|January 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Leopard-spot pattern in fluorescein angiography].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2013
Engineering Antivenom: Research Progress and Future Directions in Snakebite Envenoming Therapy.
Annals of the New York Academy of Sciences·2026
Loneliness Biases Social Engagement Decisions: Evidence From Value-Based Choice Models.
Annals of the New York Academy of Sciences·2026
Urban Climate Risk Governance and Corporate Energy Intensity: Evidence From China's Climate Adaptation City Pilots.
Annals of the New York Academy of Sciences·2026
Genetic Adaptation Accompanying the Emergence of Inkoo Virus, the European Orthobunyavirus jamestownense.
Annals of the New York Academy of Sciences·2026
Neurotechnological Natives and the Neurotechnology Shift: A Research Agenda for the Brain-as-Interface Era.
Annals of the New York Academy of Sciences·2026
Baseline Fatty Acids and Time-Averaged Executive Function in Ugandan Children With Perinatal HIV.
Annals of the New York Academy of Sciences·2026
Unlocking G4 DNA affinity through aromatic side chains: a comparative study of nickel(II), copper(II), and zinc(II) salnaphen derivatives.
Dalton transactions (Cambridge, England : 2003)·2026
Impact of adsorption-based solidification on the pharmaceutical performance and antidyslipidemic efficacy of simvastatin-ezetimibe SNEDDS.
International journal of pharmaceutics: X·2026
Mol-CADiff: text-conditional molecule generation via causality-aware autoregressive diffusion.
Nature communications·2026
Mechanistic evaluation of sulfobutylether-β-cyclodextrin complexation as a formulation strategy to enhance solubility and oral exposure of BCS Class II compounds.
International journal of pharmaceutics·2026